The demand for CBD oil and CBD-infused products is unlikely to fade as people look for natural and affordable alternatives to pharmaceuticals. By suppressing research into cannabis for decades, the FDA has now put itself in a position to try to regulate from the rearguard of the CBD movement.
Hopefully, with pressure from patients and the industry, the FDA will grant CBD nutritional supplement status, while also investing in testing to discover the benefits and side effects of short-term and long-term use.
Österreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Walgreens to sell CBD products in some storesThe drugstore chain is taking the lead from rival CVS, which announced last week it would start selling cannabidiol-based topicals.
Weiterlesen »
Walgreens to sell CBD products in 1,500 storesWalgreens will sell CBD creams, patches and sprays in nearly 1,500 stores in select states, the company told CNBC on Wednesday.
Weiterlesen »
Walgreens to sell CBD products in some storesWalgreens will sell CBD creams, patches and sprays in nearly 1,500 stores in select states, the company told CNBC on Wednesday.
Weiterlesen »
Food Infused With Cannabis Extract Takes a HitA derivative of the marijuana plant known as CBD is surging in popularity as an ingredient in food and drinks, but the fledgling industry faces an unusual complication: CBD, or cannabidiol, is now also a prescription drug.
Weiterlesen »
Betting big on CBD: How to start a business few people understandAs CBD popularity explodes, new products are flooding the market. But with little regulation, how how can consumers know what’s actually good? For Nick Aragonesi, owner of the CBD Superstore in Queens, New York, that’s the problem he tackles every day.
Weiterlesen »
Flood of products containing marijuana extract puts FDA in a bindCBD is blurring the line between a drug and a dietary supplement and testing how much the government can police health claims
Weiterlesen »
Flood of CBD products puts FDA in a bindCBD blurs the regulatory line between drugs and supplements, testing how much the government can police health claims
Weiterlesen »